P. Perimenis

Selection of diabetic patients for islet transplantation. A single-center experience.

F. Pattou, J. Kerr-Conte, M. Hazzan, 2004, Diabetes & metabolism.

Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.

V. Rohmer, P. Caron, S. Dejager, 2005, The Journal of clinical endocrinology and metabolism.

Placental antiangiogenic prolactin fragments are increased in human and rat maternal diabetes.

A. Vambergue, P. Gosset, L. Storme, 2014, Biochimica et Biophysica Acta.

Autoimmune thyroid disorders during anti-TNF alpha therapy: coincidence, paradoxical event or marker of immunogenicity?

R. Flipo, T. Pascart, P. Coquerelle, 2014, Joint, bone, spine : revue du rhumatisme.

[Riedel's thyroiditis: current aspects].

E. Leteurtre, J. Wemeau, M. Vantyghem, 2008, Presse medicale.

Eligibility of diabetic patients for islet transplantation alone.

F. Pattou, L. Touzet, M. Vantyghem, 2004, Transplantation Proceedings.

[Cystic fibrosis diabetes in adult].

B. Wallaert, M. Vantyghem, S. Marcelli-Tourvieille, 2005, Annales d'endocrinologie.

Placental antiangiogenic prolactin fragments are increased in human and rat maternal diabetes.

A. Vambergue, P. Gosset, S. Lobbens, 2014, Biochimica et biophysica acta.